Parvalbumin Corrects Slowed Relaxation in Adult Cardiac Myocytes Expressing Hypertrophic Cardiomyopathy-Linked α-Tropomyosin Mutations
- 14 May 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 94 (9), 1235-1241
- https://doi.org/10.1161/01.res.0000126923.46786.fd
Abstract
Hypertrophic cardiomyopathy mutations A63V and E180G in α-tropomyosin (α-Tm) have been shown to cause slow cardiac muscle relaxation. In this study, we used two complementary genetic strategies, gene transfer in isolated rat myocytes and transgenesis in mice, to ascertain whether parvalbumin (Parv), a myoplasmic calcium buffer, could correct the diastolic dysfunction caused by these mutations. Sarcomere shortening measurements in rat cardiac myocytes expressing the α-Tm A63V mutant revealed a slower time to 50% relengthening (T50R: 44.2±1.4 ms in A63V, 36.8±1.0 ms in controls; n=96 to 108; P+/PV−) had slower sarcomere relengthening kinetics than the controls (T90R: 199±7 ms in E180G+/PV−, 130±4 ms in E180G−/PV−; n=71 to 72), but when coexpressed with Parv, cellular relaxation was faster (T90R: 36±4 ms in E180G+/PV+). Collectively, these findings show that slow relaxation caused by α-Tm mutants can be corrected by modifying calcium handling with Parv.Keywords
This publication has 29 references indexed in Scilit:
- Targeting Diastolic Dysfunction by Genetic Engineering of Calcium Handling ProteinsTrends in Cardiovascular Medicine, 2003
- Cardiac Dysfunction in Hypertrophic Cardiomyopathy Mutant Tropomyosin Mice Is Transgene-Dependent, Hypertrophy-Independent, and Improved by β-BlockadeCirculation Research, 2002
- The failing heartNature, 2002
- A Familial Hypertrophic Cardiomyopathy α -Tropomyosin Mutation Causes Severe Cardiac Hypertrophy and Death in MiceJournal of Molecular and Cellular Cardiology, 2001
- In vivo acceleration of heart relaxation performance by parvalbumin gene deliveryJCI Insight, 2001
- Effect of Hypertrophic Cardiomyopathy Mutations in Human Cardiac Muscle α -tropomyosin (Asp175Asn and Glu180Gly) on the Regulatory Properties of Human Cardiac Troponin Determined by in vitro Motility AssayJournal of Molecular and Cellular Cardiology, 2000
- Nut consumption, lipids, and risk of a coronary eventClinical Cardiology, 1999
- Dietary approaches to stop hypertension (DASH) in clinical practice: A primary care experienceClinical Cardiology, 1999
- Thin Filament-Mediated Regulation of Cardiac ContractionAnnual Review of Physiology, 1996
- Diminished post-rest potentiation of contractile force in human dilated cardiomyopathy. Functional evidence for alterations in intracellular Ca2+ handling.JCI Insight, 1996